glp-1 risks Agonists In Obesity 10 GLP-1 Side Effects You
Description
(GLP-1 class drugs show clear protective effects)
Abbreviations AMPK: AMP-activated protein kinase DPP-4: Dipeptidyl peptidase-4 GIP: Glucose-dependent insulinotropic polypeptide GLP-1: Glucagon-like peptide 1 PPAR: Peroxisome proliferator-activated receptor References Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
phase 3 signaled ~15% weight loss at top dose in obesity
10.1038/379069a0 70 VallofD.KalafateliA
Zealand is also investigating a drug targeting amylin which they think could be used in co-formulation with other peptides including GLP-1
The feeling of fullness helps you eat less, which supports weight loss and better blood sugar control
